Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
IM Cannabis Corp ( (TSE:IMCC) ) has shared an announcement.
IM Cannabis Corp. is actively participating in an anti-dumping investigation regarding cannabis imports from Canada, engaging with the Advisory Committee to present arguments against the imposition of a dumping tax. The company re-launched a high-THC premium cannabis strain in Israel and introduced two new strains under the BLKMKT brand. The company is facing challenges due to global inflation, supply chain issues, and geopolitical tensions, including the Ukraine war and the conflict between Hamas and Israel. These factors are affecting the company’s operations, but upcoming regulatory reforms in Israel’s medical cannabis sector may positively impact its business.
More about IM Cannabis Corp
IM Cannabis Corp. operates in the cannabis industry, focusing on the distribution and retail of medical cannabis in Israel, with strategic investments and growth opportunities in Israel and Europe. The company aims to build market leadership in the European medical cannabis market and prepare for the potential legalization of the recreational market.
YTD Price Performance: 10.96%
Average Trading Volume: 92,107
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.14M
Find detailed analytics on IMCC stock on TipRanks’ Stock Analysis page.
